We Should--And We Can--Help Lift Eastern European Research Back Onto Its Feet

When East VGermany fused with West Germany, the state support of science in the former communist sector came to an end. However, despite some inevitable job insecurity, it appears that East German scientists will, for the most part, be able to go on working as the fusion of the two nations continues. Some of them will be displaced, of course, by job-hungry young scientists of West Germany; but others will be able to hang on to their university positions. For a while, their salaries will be a fr

Written byVon Borstel
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In Czechoslovakia and Hungary, however, as well as in other Eastern European nations, the outlook for scientists is brutal. There now is no money for research, and talented scientists there need help to get their science, their economies, and their nations running again. Inside Germany, a program for upgrading East German scientists to West German standards has begun. Perhaps such a program could be mimicked to benefit other Eastern European nations. They need a Western equivalent of what West Germany is doing for East Germany.

One can infer from the number of career opportunity ads in the well-read science journals that there is reasonable funding available in the United States for postdoctoral fellows and research associates. Of course, the great majority of funding disbursed to scientists by the U.S. government is for American citizens only. But if the rules were to be disengaged for a brief time, some funding could ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies